Get the Stockscreener App
4.84
0.21%
-0.010
After Hours:
4.78
-0.06
-1.24%
Pulmatrix Inc stock is traded at $4.84, with a volume of 3,242.
It is down -0.21% in the last 24 hours and up +6.26% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.85
Open:
$4.85
24h Volume:
3,242
Relative Volume:
0.26
Market Cap:
$17.68M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-2.0083
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
+0.57%
1M Performance:
+6.26%
6M Performance:
-28.51%
1Y Performance:
+142.00%
1-Day Range:
$4.78
$4.91
1-Week Range:
$4.50
$5.235
52-Week Range:
$1.97
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.84 | 17.71M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Evaluating Pulmatrix Inc. with trendline analysisPortfolio Performance Summary & Safe Entry Trade Signal Reports - newser.com
Is Pulmatrix Inc. stock gaining market shareJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Will Pulmatrix Inc. stock deliver consistent dividendsTreasury Yields & High Accuracy Trade Signal Alerts - newser.com
Is Pulmatrix Inc. stock a good choice for value investors2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Why Pulmatrix Inc. stock attracts high net worth investors2025 Key Highlights & Entry Point Confirmation Alerts - newser.com
Will Pulmatrix Inc. stock recover after recent dropJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transitionWeekly Investment Recap & Consistent Return Investment Signals - newser.com
Real time pattern detection on Pulmatrix Inc. stockOil Prices & Free Technical Confirmation Trade Alerts - newser.com
Is Pulmatrix Inc. stock attractive for long term wealth buildingJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Is it time to cut losses on Pulmatrix Inc.Long Setup & Free Technical Confirmation Trade Alerts - newser.com
Is it too late to sell Pulmatrix Inc.July 2025 Big Picture & Trade Opportunity Analysis - newser.com
Can Pulmatrix Inc. (2PU) stock double in coming yearsIPO Watch & Free Fast Gain Swing Trade Alerts - newser.com
Risk adjusted return profile for Pulmatrix Inc. analyzed2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Combining machine learning predictions for Pulmatrix Inc.Weekly Investment Summary & Expert Approved Trade Ideas - newser.com
Best data tools to analyze Pulmatrix Inc. stock2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
Is Pulmatrix Inc. stock a bargain at current levelsPortfolio Growth Summary & Weekly High Return Stock Forecasts - newser.com
Heatmap analysis for Pulmatrix Inc. and competitorsJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Is Pulmatrix Inc. forming a bottoming base2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):